---

$4.56

+0.2150 ( +4.95% ) 30.0K

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-06-06	Buy	21674.00	Encrantz Staffan
2025-06-03	Buy	42753.00	Encrantz Staffan
2025-05-29	Buy	41346.00	Encrantz Staffan
2024-12-09	Buy	5000.00	Raheja Manohar K.
2024-12-05	Buy	3376.00	Raheja Manohar K.
2024-12-03	Buy	4624.00	Raheja Manohar K.
2024-11-21	Buy	2000.00	Raheja Manohar K.
2024-07-03	Sale	-3525.00	Park Sam Boong
2024-07-03	Sale	-10497.00	Bauerlein Alison
2024-07-03	Sale	-5055.00	HAYDEN JEREMY B.